Retifanlimab and Epacadostat in Combination With Radiation and Bevacizumab in Patients With Recurrent Gliomas
Clinical trial NCT03532295 · COMPLETED
Trial details
- NCT number
- NCT03532295
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-20
- Primary completion
- 2024-07-26
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.